BackgroundWe evaluated the possibility of restoring a physiologic vascular wall using undifferentiated mesenchymal stem cells (MSCs) seeded on a polyurethane vascular prosthesis.MethodsUndifferentiated MSCs were seeded on a vascular prosthesis and implanted into Wistar male rats (weight, 350 g) to investigate differentiation into smooth muscle cells and to determine graft endothelialization in vivo.ResultsSeeded or nonseeded grafts were surgically implanted. Undifferentiated MSCs were first labelled for green fluorescent protein. After 2 weeks in vivo, MSC that were initially self-expanded on the graft in a monolayer were organized in a multicellular layer mimicking media of aortic adjacent wall. They coexpressed green fluorescent protein a...
Many preclinical evaluations of autologous small-diameter tissue-engineered vascular grafts (TEVGs) ...
Many preclinical evaluations of autologous small-diameter tissue-engineered vascular grafts (TEVGs) ...
Current challenges in vascular medicine (e.g., bypass grafting, stenting, and angioplasty.) have dri...
BackgroundWe evaluated the possibility of restoring a physiologic vascular wall using undifferentiat...
ObjectivesThere is significant room for improvement in the development of tissue-engineered blood ve...
BackgroundArterial bypass graft implantation remains the primary therapy for patients with advanced ...
Vascular tissue engineering is aimed at developing regenerative vascular grafts to restore tissue fu...
Short-term thrombotic occlusion and compliance mismatch hamper clinical use of synthetic small-diame...
Short-term thrombotic occlusion and compliance mismatch hamper clinical use of synthetic small-diame...
Short-term thrombotic occlusion and compliance mismatch hamper clinical use of synthetic small-diame...
Limited autologous vascular graft availability and poor patency rates of synthetic grafts for bypass...
Short-term thrombotic occlusion and compliance mismatch hamper clinical use of synthetic small-diame...
Objectives—Mesenchymal stem cells (MSCs) are one of a number of cell types undergoing extensive inve...
Limited autologous vascular graft availability and poor patency rates of synthetic grafts for bypass...
Aim: After in vivo implantation of cell-loaded devices, only the cells close to the capillaries can ...
Many preclinical evaluations of autologous small-diameter tissue-engineered vascular grafts (TEVGs) ...
Many preclinical evaluations of autologous small-diameter tissue-engineered vascular grafts (TEVGs) ...
Current challenges in vascular medicine (e.g., bypass grafting, stenting, and angioplasty.) have dri...
BackgroundWe evaluated the possibility of restoring a physiologic vascular wall using undifferentiat...
ObjectivesThere is significant room for improvement in the development of tissue-engineered blood ve...
BackgroundArterial bypass graft implantation remains the primary therapy for patients with advanced ...
Vascular tissue engineering is aimed at developing regenerative vascular grafts to restore tissue fu...
Short-term thrombotic occlusion and compliance mismatch hamper clinical use of synthetic small-diame...
Short-term thrombotic occlusion and compliance mismatch hamper clinical use of synthetic small-diame...
Short-term thrombotic occlusion and compliance mismatch hamper clinical use of synthetic small-diame...
Limited autologous vascular graft availability and poor patency rates of synthetic grafts for bypass...
Short-term thrombotic occlusion and compliance mismatch hamper clinical use of synthetic small-diame...
Objectives—Mesenchymal stem cells (MSCs) are one of a number of cell types undergoing extensive inve...
Limited autologous vascular graft availability and poor patency rates of synthetic grafts for bypass...
Aim: After in vivo implantation of cell-loaded devices, only the cells close to the capillaries can ...
Many preclinical evaluations of autologous small-diameter tissue-engineered vascular grafts (TEVGs) ...
Many preclinical evaluations of autologous small-diameter tissue-engineered vascular grafts (TEVGs) ...
Current challenges in vascular medicine (e.g., bypass grafting, stenting, and angioplasty.) have dri...